MTHFR and fatty liver disease: Reduced MTHFR and SAM levels and increased SAH levels in the liver in addition to mild micro-alveolar hepatic steatosis reportedly influence the inflammatory and lipid pathways in a murine model (Raghubeer and Matsha, 2021).